Review article: Advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction

22Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Summary Background In cirrhosis, portal hypertension is associated with a spectrum of renal dysfunction that has significant implications for morbidity and mortality. Aim To discuss recent progress in the patho-physiological mechanisms and therapeutic options for portal hypertension-related renal dysfunction. Methods A literature search using Pubmed was performed. Results Portal hypertension-related renal dysfunction occurs in the setting of marked neuro-humoral and circulatory derangement. A systemic inflammatory response is a pathogenetic factor in advanced disease. Such physiological changes render the individual vulnerable to further deterioration of renal function. Patients are primed to develop acute kidney injury when exposed to additional 'hits', such as sepsis. Recent progress has been made regarding our understanding of the aetiopathogenesis. However, treatment options once hepatorenal syndrome develops are limited, and prognosis remains poor. Various strategies to prevent acute kidney injury are suggested. Conclusion Prevention of acute kidney injury in high risk patients with cirrhosis and portal hypertension-related renal dysfunction should be a clinical priority. © 2014 John Wiley & Sons Ltd.

Cite

CITATION STYLE

APA

Leithead, J. A., Hayes, P. C., & Ferguson, J. W. (2014, April). Review article: Advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.12653

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free